<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03820102</url>
  </required_header>
  <id_info>
    <org_study_id>IR,VitD in HCV</org_study_id>
    <nct_id>NCT03820102</nct_id>
  </id_info>
  <brief_title>Impact of Metabolic Changes and Vitamin D Status on Virological Response in Patients With HCV Infection Treated by DAAs</brief_title>
  <official_title>Impact of Metabolic Changes and Vitamin D Status on Virological Response in Patients With Hepatitis C Viral Infection Treated by Direct Acting Antiviral Drugs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Study Changes in lipid profile and the impact of Insulin resistance on virological&#xD;
           response in patients with Hepatitis C viral infection treated by Direct Acting Antiviral&#xD;
           agents&#xD;
&#xD;
        2. The assessment of serum vitamin D levels in HCV infected patients and predictive value&#xD;
           of pre-treatment serum vitamin D level for achieving sustained virological response at&#xD;
           12 weeks post-treatment&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients and methods:&#xD;
&#xD;
      This cross-sectional study will include 100patients of chronic HCV infection who attend El&#xD;
      Raghy Assiut university Hospital, either inpatients or outpatients. Chronic HCV infection&#xD;
      will be diagnosed based on detectable HCV RNA with anti-HCV Ab in patient with clinical&#xD;
      and/or ultrasonographic criteria of chronic liver disease.&#xD;
&#xD;
      Patients will receive treatment to HCV by DAAs and follow up for 12 weeks to confirm&#xD;
      sustained virological response&#xD;
&#xD;
      Method:&#xD;
&#xD;
      Patients presenting in this study will be subjected to the following:&#xD;
&#xD;
        1. Full history and clinical evaluation.&#xD;
&#xD;
        2. Body weight (kg) and height (m).&#xD;
&#xD;
        3. BMI will calculate as weight divided by squared height (kg/m2).&#xD;
&#xD;
        4. Waist circumference will measured at a level midway between the lowest rib and the iliac&#xD;
           crest, and the hip circumference at the level of the great trochanters, with the legs&#xD;
           close together.&#xD;
&#xD;
        5. Blood pressure (mmHg) was measured twice in the upper arm after a 10-min period of rest&#xD;
           and taken an average.&#xD;
&#xD;
      Laboratory investigations will include:&#xD;
&#xD;
        -  Complete blood count (CBC)&#xD;
&#xD;
        -  Liver function test&#xD;
&#xD;
        -  HCV Ab and HCV RNA by PCR&#xD;
&#xD;
        -  HBs Ag&#xD;
&#xD;
        -  Alpha fetoprotein&#xD;
&#xD;
        -  Lipid profile&#xD;
&#xD;
        -  Serum urea and creatinine&#xD;
&#xD;
        -  Fasting blood sugar (FBG)and Serum fasting insulin level&#xD;
&#xD;
        -  Insulin resistance determined via Homeostasis Model Assessment (HOMA-IR) IR = fasting&#xD;
           insulin (µu/ml) × fasting glucose (mmol/L)&#xD;
           ----------------------------------------------------------------- 22.5 An index value of&#xD;
           ˃ 2. 5 was defined as IR (Huang et al., 2011)&#xD;
&#xD;
        -  Vitamin D level:&#xD;
&#xD;
      Vitamin D deficiency wasdefined as a 25 (OH)-vitamin D serum level &lt; 20 ng/mL, vitaminD&#xD;
      insufficiency as 25 (OH)-vitamin D levels of 20 - 29.9ng/mL, and normal vitamin D levels ≥ 30&#xD;
      ng/mL (Holick MF et al.,2011)&#xD;
&#xD;
        -  Abdominal Ultrasound&#xD;
&#xD;
        -  Electrocardiogram (ECG)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">March 2019</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SVR12</measure>
    <time_frame>12 week after treatment</time_frame>
    <description>sustained virological response 12 week after treatment</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>HCV</condition>
  <arm_group>
    <arm_group_label>Vit D deficiency</arm_group_label>
    <description>Chronic HCV patients with vitamin D deficiency Sustained virological response after treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Vit D</arm_group_label>
    <description>Chronic HCV patients with normal vitamin D level Sustained virological response after treatment</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        1. Full history and clinical evaluation.&#xD;
&#xD;
          2. Body weight and height&#xD;
&#xD;
          3. BMI will calculate as weight divided by squared height (kg/m2)&#xD;
&#xD;
          4. Waist circumference&#xD;
&#xD;
          5. Blood pressure (mmHg)&#xD;
&#xD;
        Laboratory investigations will include:&#xD;
&#xD;
          -  Complete blood count (CBC)&#xD;
&#xD;
          -  Liver function test&#xD;
&#xD;
          -  HCV Ab and HCV RNA by PCR&#xD;
&#xD;
          -  HBs Ag&#xD;
&#xD;
          -  Alpha fetoprotein&#xD;
&#xD;
          -  Lipid profile&#xD;
&#xD;
          -  Serum urea and creatinine&#xD;
&#xD;
          -  Fasting blood sugar and Serum fasting insulin level&#xD;
&#xD;
          -  Insulin resistance determined via Homeostasis Model Assessment (HOMA-IR) IR = fasting&#xD;
             insulin (µu/ml) × fasting glucose (mmol/L)&#xD;
&#xD;
        22.5 An index value of ˃ 2. 5 was defined as IR (Huang et al., 2011)&#xD;
&#xD;
          -  Vitamin D level:&#xD;
&#xD;
          -  Abdominal Ultrasound&#xD;
&#xD;
          -  Electrocardiogram&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chronic HCV will receive DAAs for treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Decompensated liver cirrhosis, hepatocellular carcinoma, history of liver transplant&#xD;
&#xD;
          2. Co-existing liver disease (hepatitis B virus, autoimmune hepatitis, human&#xD;
             immunodeficiency virus)&#xD;
&#xD;
          3. Extra-hepatic malignancy except after two years of disease free interval.&#xD;
&#xD;
          4. Patients with diabetes mellitus.&#xD;
&#xD;
          5. Patients with Chronic kidney disease.&#xD;
&#xD;
          6. Pregnancy or in ability to use effective contraception.&#xD;
&#xD;
          7. Patients with history of using lipid lowering therapy&#xD;
&#xD;
          8. relapser or failure of previous HCV treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Laila Abd Elbaky, profesor</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed H Abdelgawad, specialist</last_name>
    <phone>01008778754</phone>
    <email>d_m_h_80@hotmail.com</email>
  </overall_contact>
  <results_reference>
    <citation>Janovy J Jr. Problems in the comparative physiology of some trypanosomatid flagellates. Acta Trop. 1977 Jun;34(2):177-84.</citation>
    <PMID>19960</PMID>
  </results_reference>
  <results_reference>
    <citation>Selhub J, Rosenberg IH. Demonstration of high-affinity folate binding activity associated with the brush border membranes of rat kidney. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3090-3.</citation>
    <PMID>28521</PMID>
  </results_reference>
  <results_reference>
    <citation>Ramachandran N, Colman RF. Evidence for a critical glutamyl and an aspartyl residue in the function of pig heart diphosphopyridine nucleotide dependent isocitrate dehydrogenase. Biochemistry. 1977 Apr 19;16(8):1564-73.</citation>
    <PMID>15585</PMID>
  </results_reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>January 25, 2019</study_first_submitted>
  <study_first_submitted_qc>January 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2019</study_first_posted>
  <last_update_submitted>February 3, 2019</last_update_submitted>
  <last_update_submitted_qc>February 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohamed Hassan Abdelgawad</investigator_full_name>
    <investigator_title>Gastroenterologest and hepatologest, doctor in Assiut Police Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

